- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02169024
Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: "Expect With Me"
This study addresses the intractable challenges of adverse birth outcomes, including preterm delivery and low birthweight, by proposing the development, implementation and evaluation of a model of group prenatal care that could be scaled nationally. Group prenatal care models have been demonstrated through rigorous research to provide significantly improved birth outcomes with implications for maternal-child health and substantial cost savings. However, group prenatal care is currently available to only a small fraction of the more than four million women who give birth annually in the US. Through the development, implementation and evaluation of a new model of group prenatal care, we will create an outcomes-focused model of group prenatal care that will be scalable nationally with an eye toward improving US birth outcomes.
The long-term objective of the proposed study is to reduce the risk for adverse perinatal outcomes during and after pregnancy among women and families receiving prenatal care in health centers in 3 geographic locations serving vulnerable populations: Hidalgo County Texas, Nashville Tennessee, and Detroit Michigan. We will develop, disseminate, and evaluate a new and improved model of group prenatal care, "Expect with Me," based on our previous research on group models of prenatal care, which has already yielded favorable behavioral and biological results in two randomized controlled trials.
We hypothesize that, relative to women who receive standard individual prenatal care, the women who receive "Expect with Me" group prenatal care will be significantly more likely to:
- have better perinatal outcomes, including better health behaviors during pregnancy (e.g., nutrition, physical activity), better birth outcomes (e.g., decreased preterm labor, low birthweight, Neonatal Intensive Care Unit stays), and better postpartum indicators (e.g., increased breastfeeding);
- report greater change in risk-related behaviors and psychosocial characteristics that could be considered potential mechanisms for the program's effectiveness;
- have lower rates of sexually transmitted diseases and rapid repeat pregnancy one year postpartum;
- have lower healthcare costs through improved outcomes (e.g., appropriate care utilization, fewer complications, reduced NICU admissions/length of stays)
Comparisons based on propensity-score matched sample of women receiving standard individual prenatal care at the same clinical sites.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This study addresses the intractable challenges of adverse birth outcomes, including preterm delivery and low birthweight, by proposing the development, implementation and evaluation of a model of group prenatal care that could be scaled nationally. Group prenatal care models have been demonstrated through rigorous research to provide significantly improved birth outcomes with implications for maternal-child health and substantial cost savings. However, group prenatal care is currently available to only a small fraction of the more than four million women who give birth annually in the US. Through the development, implementation and evaluation of a new model of group prenatal care, we will create an outcomes-focused model of group prenatal care that will be scalable nationally with an eye toward improving US birth outcomes.
Specific Aims:
The long-term objective of the proposed study is to reduce the risk for adverse perinatal outcomes during and after pregnancy among women and families receiving prenatal care in health centers in 3 geographic locations serving vulnerable populations: Hidalgo County Texas, Nashville Tennessee, and Detroit Michigan. We will develop, disseminate, and evaluate a new and improved model of group prenatal care, "Expect with Me," based on our previous research on group models of prenatal care, which has already yielded favorable behavioral and biological results in two randomized controlled trials. The overall objective of this project is to improve maternal health and reduce adverse birth outcomes. We will meet this objective by achieving three specific goals:
- Develop a new and improved model of group prenatal care, including curriculum, training materials, IT infrastructure and marketing materials to support broad adoption of group prenatal care, enhance consumer experience, monitor patient outcomes, and ensure national scalability.
- Implement group prenatal care in three communities at high risk for adverse perinatal outcomes (Hidalgo County TX, Nashville TN, Detroit MI), engaging and training providers in group facilitation and the established curriculum, engaging patients through improved in-reach and outreach strategies, and implementing IT infrastructure to improve uptake, patient experience, and sustainability through the monitoring of patient outcomes.
- Evaluate the effect of implementing group prenatal care through a rigorous process and outcome evaluation that identifies any barriers to national scalability and examines maternal health and birth outcomes and resultant cost implications.
Specific Study Hypotheses
We hypothesize that, relative to women who receive standard individual prenatal care, the women who receive "Expect with Me" group prenatal care will be significantly more likely to:
- have better perinatal outcomes, including better health behaviors during pregnancy (e.g., nutrition, physical activity), better birth outcomes (e.g., decreased preterm labor, low birthweight, Neonatal Intensive Care Unit stays), and better postpartum indicators (e.g., increased breastfeeding);
- report greater change in risk-related behaviors and psychosocial characteristics that could be considered potential mechanisms for the program's effectiveness;
- have lower rates of sexually transmitted diseases and rapid repeat pregnancy one year postpartum;
- have lower healthcare costs through improved outcomes (e.g., appropriate care utilization, fewer complications, reduced NICU admissions/length of stays)
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Michigan
-
Detroit, Michigan, Stati Uniti, 48201
- Wayne State University
-
-
Tennessee
-
Nashville, Tennessee, Stati Uniti, 37232
- Vanderbilt University Medical Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- less than 24 weeks pregnant
- able to attend groups conducted in English or Spanish
- consent to share their data with the study
Exclusion Criteria:
- severe medical problem requiring individual care only, as determined by the participating clinical practice
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Expect With Me group prenatal care
receiving prenatal care through an Expect With Me group
|
Expect With Me group prenatal care was designed based on: principles of group care; evidence from RCTs demonstrating improved birth outcomes; ACOG clinical guidelines; and research on patient and provider engagement through technology.
Designed with national dissemination as a primary consideration, Expect With Me incorporates best evidence-based aspects of existing models of group care, with a novel IT platform to improve patient engagement and support, enhance health behaviors and decision making, connect providers and patients, and improve health service delivery.
Expect With Me provides care to groups of 8-12 women of the same gestational age, implemented after initial individual assessment through delivery.
Group visits are 90-120 minutes each, and follow a structured curriculum that incorporates standard content of prenatal care, and emphasizes critical health issues relevant to pregnancy, such as nutrition, physical activity, stress/mental health and sexual health.
Altri nomi:
|
|
Comparatore attivo: Individual Care Only
Standard of Care- individual prenatal care
|
Standard of care- individual prenatal care
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Risk of preterm birth incidence
Lasso di tempo: up to 37 weeks gestation
|
Incidence risk of delivery before 37 weeks gestation
|
up to 37 weeks gestation
|
|
Risk of low birth weight incidence
Lasso di tempo: delivery
|
Incidence risk of infant weight at birth < 2500 grams
|
delivery
|
|
Risk of small for gestational age incidence
Lasso di tempo: delivery
|
Incidence risk of infant weight below the 10th percentile for the gestational age at birth
|
delivery
|
|
Risk of neonatal intensive care unit (NICU) admission incidence
Lasso di tempo: birth
|
Incidence risk of being admitted to the neonatal intensive care unit (NICU) at birth
|
birth
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
breastfeeding
Lasso di tempo: 6 and 12 months postpartum
|
initiation and duration of breastfeeding
|
6 and 12 months postpartum
|
|
nutrition
Lasso di tempo: 2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum
|
nutritional choices, food security, and use of mindful eating practices
|
2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum
|
|
physical activity
Lasso di tempo: 2nd and 3rd trimester and 6 and 12 months postpartum
|
level of physical activity in a typical week
|
2nd and 3rd trimester and 6 and 12 months postpartum
|
|
readiness for labor and delivery
Lasso di tempo: measured at 2nd and third trimester
|
readiness for labor and delivery
|
measured at 2nd and third trimester
|
|
readiness for taking care of baby
Lasso di tempo: 2nd and 3rd trimester of pregnancy
|
readiness for taking care of baby
|
2nd and 3rd trimester of pregnancy
|
|
social support
Lasso di tempo: 2nd and 3rd trimester and 6 and 12 months postpartum
|
multidimensional scale of perceived social support subscale
|
2nd and 3rd trimester and 6 and 12 months postpartum
|
|
condom use self-efficacy
Lasso di tempo: 2nd and 3rd trimester and 6 and 12 months postpartum
|
condom use self efficacy scale
|
2nd and 3rd trimester and 6 and 12 months postpartum
|
|
substance use
Lasso di tempo: 2nd and 3rd trimester and 6 and 12 months postpartum
|
use of cigarettes, alcohol, and drugs
|
2nd and 3rd trimester and 6 and 12 months postpartum
|
|
care satisfaction
Lasso di tempo: 3rd trimester
|
satisfaction with Expect With Me group prenatal care and use of program components
|
3rd trimester
|
|
adherence to medical recommendations
Lasso di tempo: 6 & 12 months postpartum
|
adherence to medical recommendations (e.g., 6-week postpartum check, pediatric visits, vaccinations, infant feeding)
|
6 & 12 months postpartum
|
|
postpartum body mass index
Lasso di tempo: measured at 6 and 12 months postpartum
|
individual's body weight divided by the square of their height (kg/m2)
|
measured at 6 and 12 months postpartum
|
|
maternal weight gain
Lasso di tempo: measured at 2nd and 3rd trimester and birth
|
weight gain as compared to medical recommendations
|
measured at 2nd and 3rd trimester and birth
|
|
mode of delivery
Lasso di tempo: delivery
|
mode of delivery (e.g., cesarean, vaginal)
|
delivery
|
|
sexual risk: condom use
Lasso di tempo: measured at 2nd and 3rd trimester and 6 and 12 months postpartum
|
condom use percent (0-100%)
|
measured at 2nd and 3rd trimester and 6 and 12 months postpartum
|
|
sexual risk: contraceptive use (LARC)
Lasso di tempo: measured at 2nd and 3rd trimester and 6 and 12 months postpartum
|
use of other contraceptives to prevent pregnancy (no/yes)
|
measured at 2nd and 3rd trimester and 6 and 12 months postpartum
|
|
sexual risk: number of sexual partners
Lasso di tempo: measured at 2nd and 3rd trimester and 6 and 12 months postpartum
|
number of partners
|
measured at 2nd and 3rd trimester and 6 and 12 months postpartum
|
|
sexual risk: sexually transmitted infection
Lasso di tempo: measured at 2nd and 3rd trimester and 6 and 12 months postpartum
|
sexually transmitted infection (no/yes, during pregnancy or incident postpartum)
|
measured at 2nd and 3rd trimester and 6 and 12 months postpartum
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
nurse visitation
Lasso di tempo: 2nd and 3rd trimester of pregnancy
|
participation in a nurse visitation program
|
2nd and 3rd trimester of pregnancy
|
|
sexual debut
Lasso di tempo: 2nd trimester pregnancy
|
age at first intercourse
|
2nd trimester pregnancy
|
|
living situation
Lasso di tempo: 2nd and 3rd trimester and 6 and 12 months postpartum
|
where and with whom they live with and the stability of their housing
|
2nd and 3rd trimester and 6 and 12 months postpartum
|
|
transfer of motivation
Lasso di tempo: 2nd and3rd trimester and 6 and 12 months postpartum
|
relation of motivation for self and baby's health
|
2nd and3rd trimester and 6 and 12 months postpartum
|
|
confidence in parenting skills
Lasso di tempo: 6 and 12 months postpartum
|
confidence in parenting skills
|
6 and 12 months postpartum
|
|
intimate partner violence
Lasso di tempo: measured at 2nd and 3rd trimester and 6 and 12 months postpartum
|
perpetration and victimization of violence by an intimate partner
|
measured at 2nd and 3rd trimester and 6 and 12 months postpartum
|
|
perceived stress
Lasso di tempo: 2nd and 3rd trimester and 6 and 12 months postpartum
|
stress level as reported by patient
|
2nd and 3rd trimester and 6 and 12 months postpartum
|
|
depressive symptomatology
Lasso di tempo: 2nd and 3rd trimester of pregnancy
|
patient endorsement of depressive symptoms
|
2nd and 3rd trimester of pregnancy
|
|
perceived discrimination
Lasso di tempo: 2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum
|
patient experiences of discrimination
|
2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum
|
|
resilience
Lasso di tempo: 2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum
|
shift and persist scale
|
2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Jeannette R Ickovics, Ph.D., Yale School of Public Health
- Direttore dello studio: Jessica B Lewis, PhD, MFT, Yale School of Public Health
Pubblicazioni e link utili
Pubblicazioni generali
- Lewis JB, Cunningham SD, Shabanova V, Hassan SS, Magriples U, Rodriguez MG, Ickovics JR. Group prenatal care and improved birth outcomes: Results from a type 1 hybrid effectiveness-implementation study. Prev Med. 2021 Dec;153:106853. doi: 10.1016/j.ypmed.2021.106853. Epub 2021 Oct 20.
- Cunningham SD, Lewis JB, Thomas JL, Grilo SA, Ickovics JR. Expect With Me: development and evaluation design for an innovative model of group prenatal care to improve perinatal outcomes. BMC Pregnancy Childbirth. 2017 May 18;17(1):147. doi: 10.1186/s12884-017-1327-3.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 1304011772
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .